Vertex Pharmaceuticals Inc. (VRTX): Price and Financial Metrics

VRTX POWR Grades

• Quality is the dimension where VRTX ranks best; there it ranks ahead of 98.69% of US stocks.
• VRTX's strongest trending metric is Momentum; it's been moving up over the last 179 days.
• VRTX ranks lowest in Momentum; there it ranks in the 25th percentile.

VRTX Stock Summary

• With a market capitalization of $74,255,278,418, VERTEX PHARMACEUTICALS INC has a greater market value than 97.58% of US stocks.
• Of note is the ratio of VERTEX PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; only 11.47% of US stocks have a lower such ratio.
• VRTX's price/sales ratio is 8.89; that's higher than the P/S ratio of 87.48% of US stocks.
• If you're looking for stocks that are quantitatively similar to VERTEX PHARMACEUTICALS INC, a group of peers worth examining would be MU, AMAT, INTC, LRCX, and REGN.
• Visit VRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.vrtx.com.

VRTX Valuation Summary

• VRTX's price/sales ratio is 8.7; this is 357.89% higher than that of the median Healthcare stock.
• Over the past 243 months, VRTX's price/earnings ratio has gone up 38.7.

Below are key valuation metrics over time for VRTX.

VRTX Growth Metrics

The 3 year net income to common stockholders growth rate now stands at 13.72%.
• Its 4 year revenue growth rate is now at 190.09%.
• Its year over year net income to common stockholders growth rate is now at -11.26%.

Over the past 52 months, VRTX's revenue has gone up $5,935,692,000.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	8,350.425	4,018.212	3,194.638
2022-03-31	7,947.595	2,678.645	2,451.062
2021-12-31	7,574.4	2,643.5	2,342.1
2021-09-30	7,129.659	2,140.039	2,176.18
2021-06-30	6,683.766	2,120.568	1,991.686
2021-03-31	6,414.881	3,358.862	2,762.032

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VRTX has a Quality Grade of B, ranking ahead of 86.88% of graded US stocks.
• VRTX's asset turnover comes in at 0.564 -- ranking 66th of 681 Pharmaceutical Products stocks.
• ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.